Vergilius José Furtado de Araujo Filho

Vergilius José Furtado de Araujo Filho

Auto-generated profile, based on publicly available information

Vergilius José Furtado de Araujo Filho

Department of Head and Neck Surgery, University of São Paulo Medical School, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Revista Do Hospital Das Clinicas
Verified
Journal Article
Open access
PDF file
Pablo VargasPablo Vargas
Pablo Vargas
RGRenê Gerhard
Renê Gerhard
VFVergílius J. F. Araújo Filho
Vergílius J. F. Araújo Filho
ICInês Vieira de Castro
Inês Vieira de Castro
Salivary gland tumors constitute a highly heterogeneous histopathologic group. There are few epidemiological studies of large series of benign and malignant salivary gland tumors in Brazil. MATERIAL AND METHODS: Hospital records of 124 patients with salivary gland tumors diagnosed from January 1993 to December 1999 were reviewed. The patients were analyzed according to gender, age, size, location, and histopathology of the tumor. RESULTS AND CONCLUSIONS: Patients with benign and malignant tumors presented with a mean age of 47.7 and 48.8 years, respectively. The frequency of benign tumors was 80% (n = 99) and malignant tumors 20% (n = 25). Tumors were localized in the parotid gland 71% (n = 88), in the submandibular gland 24% (n = 30), and in the minor salivary glands 5% (n = 6). The most common benign tumors were pleomorphic adenoma in 84% (n = 84) and Warthin's tumor in 13% (n = 13). Among malignant tumors, mucoepidermoid carcinoma was the most common in 52% (n = 13), adenoid cystic carcinoma occurred in 20% (n = 5), and carcinoma ex pleomorphic adenoma was detected in 12% (n = 3).

18 July 2008 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MCMARIA CRISTINA CHAMMAS
MARIA CRISTINA CHAMMAS
VFVergilius José F. de Araujo Filho
Vergilius José F. de Araujo Filho
RMRaquel A. Moysés
Raquel A. Moysés
MBMarília D. G. Brescia
Marília D. G. Brescia
GMGrace C. Mulatti
Grace C. Mulatti
AFAlberto R. Ferraz
Alberto R. Ferraz

1 November 2009 in Thyroid®
Verified
Journal Article
Closed access
VAVergilius José Furtado de Araujo-Filho
Vergilius José Furtado de Araujo-Filho
VAVenancio Avancini Ferreira Alves
Venancio Avancini Ferreira Alves
ICInes Vieira de Castro
Ines Vieira de Castro
SLSilvia Vanessa Lourenço
Silvia Vanessa Lourenço
CCClaudio Roberto Cernea
Claudio Roberto Cernea
AFAlberto R. Ferraz
Alberto R. Ferraz
Background: The vascular endothelial growth factor (VEGF) is a major promoter of endothelial growth and migration. Some studies have shown a correlation between expression of this growth factor and prognosis in several cancers, including well-differentiated thyroid cancer. Aim: We studied VEGF expression, local invasiveness, and other prognostic factors in papillary thyroid carcinoma (PTC) to test the hypothesis that the expression of VEGF is correlated with the degree of invasion of PTC. Patients and Methods: Clinical and pathological data of 76 patients with PTC were retrospectively reviewed. Group 1 consisted of patients with gross locally invasive tumors, group 2 consisted of patients with only invasion of the thyroid capsule, and group 3 consisted of patients with noninvasive PTC. Results: VEGF expression was noted within the tumor in all groups of PTC patients but was absent in the surrounding normal tissue. Older patients had higher expression of VEGF than younger patients. The age of patients with strong reaction to VEGF was 46 ± 14 (mean ± standard deviation), and that in patients with a weaker reaction was 39 ± 16 (p < 0.05). Only 20% of patients with a follicular variant of PTC had a strong reaction to VEGF compared with 68% of patients with classical PTC (p < 0.01). Conclusions: VEGF expression appears to be an early event in the development of PTC. Whether VEGF expression promotes the progression of PTC is not known, but the answer to this question may be important in view of its greater expression in older patients, a group whose prognosis in PTC is worse.

28 November 2008 in Histopathology
Verified
Journal Article
Closed access
PDF file
VAV A F Alves
V A F Alves
SNS Nonogaki
S Nonogaki
PCP M Cury
P M Cury
VWV Wünsch‐Filho
V Wünsch‐Filho
MCM B De Carvalho
M B De Carvalho
MZM A Zago
M A Zago

1 January 2018 in Clinics
Verified
Journal Article
Open access
LMLeticia Mosca
Leticia Mosca
LSLuiz Fernando Ferraz da Silva
Luiz Fernando Ferraz da Silva
PCPaulo Campos Carneiro
Paulo Campos Carneiro
DCDanielle Azevedo Chacon
Danielle Azevedo Chacon
VAVergilius Jose Furtado de Araujo-Neto
Vergilius Jose Furtado de Araujo-Neto
CCClaudio Roberto Cernea
Claudio Roberto Cernea
Most thyroid diseases are nodular and have been investigated using ultrasound-guided fine needle aspiration biopsy (FNAB), the reports of which are standardized by the Bethesda System. Bethesda category III represents a heterogeneous group in terms of ...

31 January 2012 in Head & Neck
Verified
Journal Article
Closed access
PDF file
CCClaudio R. Cernea
Claudio R. Cernea
FHFlavio C. Hojaij
Flavio C. Hojaij
DCDorival De Carlucci
Dorival De Carlucci
MTMarcos R. Tavares
Marcos R. Tavares
VAVergilius J. Araújo–Filho
Vergilius J. Araújo–Filho
LBLenine G. Brandão
Lenine G. Brandão